The Pharmabiotic Research Institute (PRI) welcomes the European Commission's proposal for a European Biotech Act. The proposal represents a timely and important opportunity to strengthen Europe's biotechnology ecosystem by improving competitiveness, fostering innovation, facilitating investment and enhancing regulatory efficiency while maintaining the Union's high standards of public health, food safety…
PRI
PHARMABIOTIC RESEARCH INSTITUTE
NGO · Belgium · EU Transparency Register 897994636209-21
2
positions filed
in the 326 files tracked
1
legislative file
of 326 tracked
2
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 784 non-governmental organisations on this site, they rank #440 by legislative files engaged — a count of participation, not a measure of influence.
0.3
declared lobbying FTE
self-declared
€25K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2019
in the register since
Declares membership of
- No membership in any other organization
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Non-governmental organisations
- Head office
- Brussels, Belgium
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track PHARMABIOTIC in PolicySpeak: request access →
Work at PHARMABIOTIC RESEARCH INSTITUTE? so we know who speaks for it.
Their record over time
PHARMABIOTIC RESEARCH INSTITUTE filed 2 positions between 11 Jun 2025 and 5 Aug 2026, across 1 of the 326 legislative files tracked here, attaching a full position paper 2 times.
2025 · 1 filed2026 · 1 filed
What they argued
The Pharmabiotic Research Institute (PRI) is a non-profit European organisation dedicated to advancing regulatory science for microbiome-based innovations. PRI welcomes the initiative to establish a European Biotech Act to support innovation, scale-up, and competitiveness in the EU biotech sector. 1.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from PHARMABIOTIC RESEARCH INSTITUTE’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.